NCT03674060View on ClinicalTrials.gov

Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 28, 2018

Primary Completion Date

February 8, 2019

Study Completion Date

July 23, 2019

Conditions

Healthy, Male

Interventions

DRUG

SYO-1644

"100mg: SYO-1644 tablet, PO, 1 100mg tablet~150mg: SYO-1644 tablet, PO, 1 100mg tablet and 1 50mg tablet~200mg: SYO-1644 tablet, PO, 2 100mg tablet"

DRUG

Nexavar tab

Nexavar 200mg/tablet, PO, 1 tablet

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors

collaborator

Seoul National University Hospital

OTHER

lead

Samyang Biopharmaceuticals Corporation

INDUSTRY

NCT03674060 - Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter